Political

A Minnesota House panel Wednesday gave the green light to this year's version of the recreational cannabis bill.  The Commerce Committee was the first stop on a long journey that's likely to include at least a dozen more stops before reaching a pivotal floor vote.

Rep. Zack Stephenson, the Coon Rapids Democrat who is the chief author of the adult-use cannabis bill, said he's all for sticking with the same exhaustive vetting process the legislation went through when it passed the House in 2019.

2022 was the best of times for marijuana policy reform in America—but if you read the headlines or (god forbid) log onto Twitter, you could be forgiven for thinking that it was the worst.

This Orwellian doublethink is understandable if you look at it through the lens of a minute-by-minute analysis, or by only looking at the stock prices of the young, dominant players in the emerging cannabis industry. But we must keep the long game in mind when we think about ending the 85-year policy of marijuana prohibition and criminalization.

Tilray Brands Inc. reported a second-quarter net loss of US$61.6 million in its most recent quarter as it temporarily slowed cannabis production because of the "longer-than-anticipated march toward legalization" in some markets.

Among the markets whose timing is hampering the Leamington, Ont. pot company is the U.S., where its chief executive said, "we do not expect (legalization) to happen at any time in the near future."

Quick—name the first cannabis industry unicorn.

If you said Canopy Growth, or GW Pharmaceuticals, or a marijuana company currently in business, you’ve forgotten the amazing rise and fall of Medbox.

At the close of 2020, 46 nations had passed some form of marijuana legalization. Up to 44 countries passed some form of medical laws. Uruguay and Canada are two countries that legalized adult use, and Mexico and Israel will likely follow in 2021.

With reform efforts underway, investors and cannabis pros have their eyes on countries across the globe, with the expectation that international sales will spike. 

After Kamala Harris was nominated to be President Elect Joe Biden’s running mate, we knew that brighter days were ahead for the cannabis industry……..and the market seemed to agree with us.

After Joe Biden was projected to win the election, the cannabis sector recorded strong moves to the upside for almost two months. Although the sector has come off its recent highs, we believe the recent additions to President Elect Joe Biden’s cabinet send a very bullish sign to the cannabis industry.

In a huge step forward for cannabis legalization and global drug reform, the UN Commission on Narcotic Drugs (CND) voted on Wednesday to pull cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs. Under the UN’s system, Schedule IV substances are considered the most dangerous and addictive drugs.Cannabis will no longer be classified as a drug as dangerous as heroin.

President-elect Joe Biden will be good — but not great — for the cannabis industry, analysts, executives, and other experts say.

While Biden has stopped short of endorsing federal legalization, both he and Vice President-elect Kamala Harris, have campaigned on decriminalizing marijuana.

Plenty of uncertainty remains with the 2020 election, but one thing is clear: Recreational cannabis had a big night at the ballot box.

Voters in Arizona, Montana, New Jersey and South Dakota cleared cannabis for adult use, bringing the total number of states that have approved it for that purpose to 15.

After years of near-misses, Gov. Andrew Cuomo expects New York legislators to finally legalize marijuana in 2021, getting over past opposition and division for one simple reason - the state needs the money.